ATSC to provide software development services for NCI

NewsGuard 100/100 Score

ATS Corporation ("ATSC" or the "Company") (NYSE Amex: ATSC), a leading information technology company that delivers innovative technology solutions to government and commercial organizations, today announced that it has been awarded a new contract totaling $13.3 million over a five-year term with the National Cancer Institute ("NCI").  Under this contract, ATSC will continue to provide software development services for the NCI Center for Biomedical Informatics and Information Technology ("CBIIT") in support of its grants management systems.

"ATSC has provided software development services for nearly a decade in support of National Cancer Institute's administrative systems and grants process which funds significant cancer research initiatives," said ATSC Chairman and Chief Executive Officer Dr. Edward H. Bersoff.  "We are pleased to have been selected by NCI to continue performing these software development services.  This contract is especially significant because it represents our company's first major award under the Alliant government-wide acquisition vehicle, and positions us well for future increased activity under this vehicle."

Source:

ATS Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Supply chain assessment and management, optimizing pharmaceutical supply chains